A study of diazepam binding inhibitor (DBI) processing products in human cerebrospinal fluid and in postmortem human brain
Open Access
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 29 (5) , 419-428
- https://doi.org/10.1016/0028-3908(90)90162-k
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathyAnnals of Neurology, 1989
- Distribution of a putative endogenous modulator of the GABA ergic system in human brainNeurology, 1989
- Diazepam binding inhibitor-like immunoreactivity(51–70): distribution in human brain, spinal cord and peripheral tissuesBrain Research, 1989
- Diazepam binding inhibitor-like immunoreactivity (DBI-LI) in human CSFJournal of the Neurological Sciences, 1988
- Isolation and characterization of porcine diazepam‐binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin releaseEuropean Journal of Biochemistry, 1988
- Octadecaneuropeptide (ODN; ‘anxiety peptide’) displaces diazepam more potently from astrocytic than from neuronal binding sitesEuropean Journal of Pharmacology, 1986
- A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brainBrain Research, 1986
- Diazepam-Binding Inhibitor: A Neuropeptide Located in Selected Neuronal Populations of Rat BrainScience, 1985
- Neuropeptide modulation of GABA receptor Cl− channelsRegulatory Peptides, 1985
- A simple method for displaying the hydropathic character of a proteinJournal of Molecular Biology, 1982